Full Papers
Prospective 12-month ultrasound evaluation of carotid atherosclerosis, urate deposits, and musculoskeletal inflammation in newly diagnosed gout
C. Rodríguez-Alvear1, I. Calabuig2, A. Martínez-Sanchis3, M. Andrés4
- Department of Rheumatology, Dr. José Molina Orosa Hospital, Arrecife, Spain. rodriguezalvearcristina@gmail.com
- Department of Rheumatology, Dr. Balmis General University Hospital, Alicante; and Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
- Department of Rheumatology, Dr. Balmis General University Hospital, Alicante; and Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
- Department of Rheumatology, Dr. Balmis General University Hospital, Alicante; Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante; and Clinical Medicine, Miguel Hernandez University of Elche, Sant Joan D’Alacant, Spain.
CER19536
Full Papers
Received: 18/11/2025
Accepted : 10/02/2026
In Press: 06/03/2026
Abstract
OBJECTIVES:
To assess the longitudinal association between carotid atherosclerosis and ultrasound signs of urate crystal deposition and musculoskeletal inflammation in gout.
METHODS:
We carried out a single-centre, observational, prospective study including consecutive patients with crystal-proven gout from a rheumatology unit. Ultrasound assessments were performed at baseline (M0) and six months (M6) and 12 months (M12) after initiating urate-lowering therapy. Six joints and four tendons were scanned to detect urate crystal deposits (double contour, aggregates, and tophi); local inflammation was identified based on the power Doppler (PD) signal. The carotid arteries were scanned for increased intima-media thickness and atheromatous plaques according to the Mannheim consensus. The association between changes in carotid arteries, deposits, and PD signal in the M0-M6 and M6-M12 periods was studied using the chi-square and Fisher exact tests.
RESULTS:
Of the 103 patients included, 91 (88.3%) and 78 (75.7%) underwent the M6 and M12 evaluations, respectively. At M0, the mean number of locations with deposits and a positive PD signal was 9.9 (SD 4.1) and 1.1 (SD 1.1). Carotid atheromatous plaque was identified in 59%. During study, near of 97% received ULT and almost half of patients used lipid-lowering drugs. At M6, no association was found between changes in carotid and musculoskeletal variables. However, at M12, plaque regression was more common in those with an absent PD signal than in those with a persistent PD signal (64.0% vs. 28.6%, p=0.017). No association was noted with changes in crystal deposits.
CONCLUSIONS:
After 12 months of urate-lowering treatment, the absence of musculoskeletal inflammation at ultrasound in gout patients was closely linked to improvements in carotid atheromatous plaques.
